Anti‐CD20 mAb maintenance therapy vs observation
Health‐related quality of life · people with chronic lymphocytic leukaemia
1 finding from 1 review
- no estimate extracted1 study · 480 participantsLow
Findings
What do systematic reviews say?
4 questions · 4 findings · 2 reviews · Haematology
No studies found 2 · 50%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 50%Moderate 0 · 0%High 0 · 0%
Anti‐CD52 mAb maintenance therapy vs observation
Health‐related quality of life ‐ not reported · people with chronic lymphocytic leukaemia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Immunomodulatory drug maintenance therapy vs placebo/observation
Health‐related quality of life ‐ not reported · people with chronic lymphocytic leukaemia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Ruxolitinib vs best available therapy
Health‐related quality of life European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ‐C30). Scale from: 0 to 100 (a higher score means a better outcome) · Patients with treating MF
1 finding from 1 review
- Janus kinase‐1 and Janus kinase‐2 inhibitors for treating myelofibrosis 2015 · Cochrane Headline outcomes onlyno estimate extracted1 study · 96 participantsLow